# Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

> **NCT00979212** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 71 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** panitumumab
- **DRUG:** carboplatin
- **DRUG:** paclitaxel
- **PROCEDURE:** surgery

## Key facts

- **NCT ID:** NCT00979212
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2015-12
- **Final completion:** 2022-05-20
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2022-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979212, "Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00979212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*